A case of chest wall recurrence of hilar cholangiocarcinoma 10 years after R1 surgery with positive ductal margin of carcinoma in situ.
Chest wall metastasis
Hilar cholangiocarcinoma
Journal
International cancer conference journal
ISSN: 2192-3183
Titre abrégé: Int Cancer Conf J
Pays: Singapore
ID NLM: 101734231
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
received:
09
11
2019
accepted:
04
02
2020
entrez:
8
4
2020
pubmed:
8
4
2020
medline:
8
4
2020
Statut:
epublish
Résumé
Patients with cholangiocarcinoma sometimes show very slow progression and thereby exhibit long-term survival under treatment of the disease. A 72-year-old male with hilar cholangiocarcinoma underwent extended-right hemi-hepatectomy and caudate lobectomy. Pathological finding revealed a well differentiated tumor and carcinoma in situ at the bile duct margin. Routine imaging follow-up was continued for 5 years. Ten years after the surgery, the patient noticed a right-hand chest wall mass formation of 5 cm without any symptoms, and the tumor was diagnosed metastatic cholangiocarcinoma by needle biopsy. Radical resection of the metastatic tumor was performed. The pathological findings of the primary tumor and the metastatic tumor were similar. Three months later, recurrent multiple lesions were identified in the chest wall and the liver. The patient received chemotherapy. We here report a rare case of metastatic cholangiocarcinoma 10 years after hepatectomy with positive ductal margin of carcinoma in situ, implying that rare event of very late recurrence of patients with hilar cholangiocarcinoma should be taken into consideration.
Identifiants
pubmed: 32257758
doi: 10.1007/s13691-020-00400-y
pii: 400
pmc: PMC7109235
doi:
Types de publication
Journal Article
Langues
eng
Pagination
77-81Informations de copyright
© The Japan Society of Clinical Oncology 2020.
Déclaration de conflit d'intérêts
Conflict of interestThe authors have no conflicts of interest.
Références
J Gastroenterol Hepatol. 2015 Sep;30(9):1337
pubmed: 26211694
Surg Today. 2009;39(1):72-6
pubmed: 19132474
J Hepatobiliary Pancreat Sci. 2010 Jul;17(4):463-9
pubmed: 19941010
Ann Surg. 2007 May;245(5):755-62
pubmed: 17457168
Ann Surg. 2019 Aug;270(2):230-237
pubmed: 30339627
Lancet Oncol. 2019 May;20(5):663-673
pubmed: 30922733
Surg Today. 1994;24(3):280-4
pubmed: 8003873
Ann Surg. 2009 Feb;249(2):296-302
pubmed: 19212185
Clin J Gastroenterol. 2013 Dec;6(6):485-9
pubmed: 24319501
J Hepatobiliary Pancreat Sci. 2010 Jul;17(4):476-89
pubmed: 19851704
Surg Case Rep. 2017 Oct 16;3(1):110
pubmed: 29039079
Am J Surg. 2020 Jan;219(1):175-180
pubmed: 30797594
Cancer Chemother Pharmacol. 2008 Oct;62(5):849-55
pubmed: 18214482
Ann Surg. 2013 Jul;258(1):129-40
pubmed: 23059502
J Hepatobiliary Pancreat Surg. 2006;13(5):458-62
pubmed: 17013723
J Med Case Rep. 2016 Oct 26;10(1):299
pubmed: 27784337